Life in lockdown: experiences of patients with IBD during COVID-19
Harris, Richard James, Downey, Louise, Smith, Trevor R, Cummings, J R Fraser, Felwick, Richard, Gwiggner, Markus
Published in BMJ open gastroenterology (01.11.2020)
Published in BMJ open gastroenterology (01.11.2020)
Get full text
Journal Article
Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study
Harris, Clare, Harris, Richard James, Young, David, McDonnell, Martin, Clancy, Bridget, Harvey, Justin, Araujo, Carlos, Iria, Ines, Goncalves, Joao, Latter, Susan, Cummings, J. R. Fraser
Published in GastroHep (25.08.2023)
Published in GastroHep (25.08.2023)
Get full text
Journal Article
PMO-20 The IBD biosimilar to biosimilar switching study (iBiSS)
Harris, Clare, Harris, Richard James, Young, David, McDonnell, Martin, Clancy, Bridget, Harvey, Justin, Latter, Prof Susan, Fraser Cummings, JR
Published in Gut (07.11.2021)
Published in Gut (07.11.2021)
Get full text
Journal Article
Management of Crohn's disease in an immunosuppressed COVID-19-positive patient: safety-driven prioritisation of nutritional therapy as a bridge to restarting immunosuppression
Harris, Clare, Harris, Richard James, Downey, Louise, Gwiggner, Markus
Published in BMJ case reports (22.03.2021)
Published in BMJ case reports (22.03.2021)
Get full text
Journal Article
Early real-world effectiveness of ustekinumab for Crohn’s disease
Harris, Richard James, McDonnell, Martin, Young, David, Bettey, Marion, Downey, Louise, Pigott, Lucinda, Felwick, Richard, Gwiggner, Markus, Cummings, J R Fraser
Published in Frontline gastroenterology (01.03.2020)
Published in Frontline gastroenterology (01.03.2020)
Get full text
Journal Article